MyAverix Finance
SHG · Healthcare
Dashenlin Pharm Grp Co Ltd (603233)
Pharmaceutical Retailers
Dashenlin Pharm Grp Co Ltd (603233) is listed on SHG in the Healthcare sector. Industry: Pharmaceutical Retailers. As of 2026-03-28, reported market cap is $20.00B, P/E ratio is 17.39, net margin is 4.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603233
Dashenlin Pharm Grp Co Ltd (603233) — FAQ
What is Dashenlin Pharm Grp Co Ltd's market cap?
Dashenlin Pharm Grp Co Ltd (603233) has a reported market cap of $20.00B (data as of 2026-03-28).
What is 603233's P/E ratio?
The price-to-earnings (P/E) ratio for Dashenlin Pharm Grp Co Ltd (603233) is 17.39 (data as of 2026-03-28).
Does Dashenlin Pharm Grp Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Dashenlin Pharm Grp Co Ltd (603233). Check the MyAverix Finance app for the latest dividend data.
What sector is Dashenlin Pharm Grp Co Ltd in?
Dashenlin Pharm Grp Co Ltd (603233) is classified in the Healthcare sector (Pharmaceutical Retailers industry).
What exchange is 603233 listed on?
603233 is listed on SHG.
What is Dashenlin Pharm Grp Co Ltd's net margin?
Dashenlin Pharm Grp Co Ltd (603233) reports a net margin of 4.2% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.